United States Ophthalmic Drug Market Report 2017

January 2017 | 114 pages | ID: U12C23D5B7DEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Ophthalmic Drug

Revenue, means the sales value of Ophthalmic Drug

This report studies sales (consumption) of Ophthalmic Drug in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Novartis
• Allergan
• Santen
• Pfizer
• Merck
• Roche
• Bayer
• Senju
• Regeneron
• Valeant
• Ozurdex

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Prescription Drugs
• OTC Drugs

Split by applications, this report focuses on sales, market share and growth rate of Ophthalmic Drug in each application, can be divided into

• Dry Eye Drugs
• Retinal Drugs
• Infective Drugs
• Others

Contents

United States Ophthalmic Drug Market Report 2017

1 OPHTHALMIC DRUG OVERVIEW

1.1 Product Overview and Scope of Ophthalmic Drug
1.2 Classification of Ophthalmic Drug
  1.2.1 Prescription Drugs
  1.2.2 OTC Drugs
1.3 Application of Ophthalmic Drug
  1.3.1 Dry Eye Drugs
  1.3.2 Retinal Drugs
  1.3.3 Infective Drugs
  1.3.4 Others
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Ophthalmic Drug (2011-2021)
  1.4.1 United States Ophthalmic Drug Sales and Growth Rate (2011-2021)
  1.4.2 United States Ophthalmic Drug Revenue and Growth Rate (2011-2021)

2 UNITED STATES OPHTHALMIC DRUG COMPETITION BY MANUFACTURERS

2.1 United States Ophthalmic Drug Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Ophthalmic Drug Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Ophthalmic Drug Average Price by Manufactures (2015 and 2016)
2.4 Ophthalmic Drug Market Competitive Situation and Trends
  2.4.1 Ophthalmic Drug Market Concentration Rate
  2.4.2 Ophthalmic Drug Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES OPHTHALMIC DRUG SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2011-2016)

3.1 United States Ophthalmic Drug Sales and Market Share by States (2011-2016)
3.2 United States Ophthalmic Drug Revenue and Market Share by States (2011-2016)
3.3 United States Ophthalmic Drug Price by States (2011-2016)

4 UNITED STATES OPHTHALMIC DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

4.1 United States Ophthalmic Drug Sales and Market Share by Type (2011-2016)
4.2 United States Ophthalmic Drug Revenue and Market Share by Type (2011-2016)
4.3 United States Ophthalmic Drug Price by Type (2011-2016)
4.4 United States Ophthalmic Drug Sales Growth Rate by Type (2011-2016)

5 UNITED STATES OPHTHALMIC DRUG SALES (VOLUME) BY APPLICATION (2011-2016)

5.1 United States Ophthalmic Drug Sales and Market Share by Application (2011-2016)
5.2 United States Ophthalmic Drug Sales Growth Rate by Application (2011-2016)
5.3 Market Drivers and Opportunities

6 UNITED STATES OPHTHALMIC DRUG MANUFACTURERS PROFILES/ANALYSIS

6.1 Novartis
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Ophthalmic Drug Product Type, Application and Specification
    6.1.2.1 Prescription Drugs
    6.1.2.2 OTC Drugs
  6.1.3 Novartis Ophthalmic Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  6.1.4 Main Business/Business Overview
6.2 Allergan
  6.2.2 Ophthalmic Drug Product Type, Application and Specification
    6.2.2.1 Prescription Drugs
    6.2.2.2 OTC Drugs
  6.2.3 Allergan Ophthalmic Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  6.2.4 Main Business/Business Overview
6.3 Santen
  6.3.2 Ophthalmic Drug Product Type, Application and Specification
    6.3.2.1 Prescription Drugs
    6.3.2.2 OTC Drugs
  6.3.3 Santen Ophthalmic Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  6.3.4 Main Business/Business Overview
6.4 Pfizer
  6.4.2 Ophthalmic Drug Product Type, Application and Specification
    6.4.2.1 Prescription Drugs
    6.4.2.2 OTC Drugs
  6.4.3 Pfizer Ophthalmic Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  6.4.4 Main Business/Business Overview
6.5 Merck
  6.5.2 Ophthalmic Drug Product Type, Application and Specification
    6.5.2.1 Prescription Drugs
    6.5.2.2 OTC Drugs
  6.5.3 Merck Ophthalmic Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  6.5.4 Main Business/Business Overview
6.6 Roche
  6.6.2 Ophthalmic Drug Product Type, Application and Specification
    6.6.2.1 Prescription Drugs
    6.6.2.2 OTC Drugs
  6.6.3 Roche Ophthalmic Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  6.6.4 Main Business/Business Overview
6.7 Bayer
  6.7.2 Ophthalmic Drug Product Type, Application and Specification
    6.7.2.1 Prescription Drugs
    6.7.2.2 OTC Drugs
  6.7.3 Bayer Ophthalmic Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  6.7.4 Main Business/Business Overview
6.8 Senju
  6.8.2 Ophthalmic Drug Product Type, Application and Specification
    6.8.2.1 Prescription Drugs
    6.8.2.2 OTC Drugs
  6.8.3 Senju Ophthalmic Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  6.8.4 Main Business/Business Overview
6.9 Regeneron
  6.9.2 Ophthalmic Drug Product Type, Application and Specification
    6.9.2.1 Prescription Drugs
    6.9.2.2 OTC Drugs
  6.9.3 Regeneron Ophthalmic Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  6.9.4 Main Business/Business Overview
6.10 Valeant
  6.10.2 Ophthalmic Drug Product Type, Application and Specification
    6.10.2.1 Prescription Drugs
    6.10.2.2 OTC Drugs
  6.10.3 Valeant Ophthalmic Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  6.10.4 Main Business/Business Overview
6.11 Ozurdex

7 OPHTHALMIC DRUG MANUFACTURING COST ANALYSIS

7.1 Ophthalmic Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Ophthalmic Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Ophthalmic Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Ophthalmic Drug Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES OPHTHALMIC DRUG MARKET FORECAST (2016-2021)

11.1 United States Ophthalmic Drug Sales, Revenue Forecast (2016-2021)
11.2 United States Ophthalmic Drug Sales Forecast by Type (2016-2021)
11.3 United States Ophthalmic Drug Sales Forecast by Application (2016-2021)
11.4 Ophthalmic Drug Price Forecast (2016-2021)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Ophthalmic Drug
Table Classification of Ophthalmic Drug
Figure United States Sales Market Share of Ophthalmic Drug by Type in 2015
Figure Prescription Drugs Picture
Figure OTC Drugs Picture
Table Application of Ophthalmic Drug
Figure United States Sales Market Share of Ophthalmic Drug by Application in 2015
Figure Dry Eye Drugs Examples
Figure Retinal Drugs Examples
Figure Infective Drugs Examples
Figure Others Examples
Figure United States Ophthalmic Drug Sales and Growth Rate (2011-2021)
Figure United States Ophthalmic Drug Revenue and Growth Rate (2011-2021)
Table United States Ophthalmic Drug Sales of Key Manufacturers (2015 and 2016)
Table United States Ophthalmic Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Ophthalmic Drug Sales Share by Manufacturers
Figure 2016 Ophthalmic Drug Sales Share by Manufacturers
Table United States Ophthalmic Drug Revenue by Manufacturers (2015 and 2016)
Table United States Ophthalmic Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Ophthalmic Drug Revenue Share by Manufacturers
Table 2016 United States Ophthalmic Drug Revenue Share by Manufacturers
Table United States Market Ophthalmic Drug Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Ophthalmic Drug Average Price of Key Manufacturers in 2015
Figure Ophthalmic Drug Market Share of Top 3 Manufacturers
Figure Ophthalmic Drug Market Share of Top 5 Manufacturers
Table United States Ophthalmic Drug Sales by States (2011-2016)
Table United States Ophthalmic Drug Sales Share by States (2011-2016)
Figure United States Ophthalmic Drug Sales Market Share by States in 2015
Table United States Ophthalmic Drug Revenue and Market Share by States (2011-2016)
Table United States Ophthalmic Drug Revenue Share by States (2011-2016)
Figure Revenue Market Share of Ophthalmic Drug by States (2011-2016)
Table United States Ophthalmic Drug Price by States (2011-2016)
Table United States Ophthalmic Drug Sales by Type (2011-2016)
Table United States Ophthalmic Drug Sales Share by Type (2011-2016)
Figure United States Ophthalmic Drug Sales Market Share by Type in 2015
Table United States Ophthalmic Drug Revenue and Market Share by Type (2011-2016)
Table United States Ophthalmic Drug Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Ophthalmic Drug by Type (2011-2016)
Table United States Ophthalmic Drug Price by Type (2011-2016)
Figure United States Ophthalmic Drug Sales Growth Rate by Type (2011-2016)
Table United States Ophthalmic Drug Sales by Application (2011-2016)
Table United States Ophthalmic Drug Sales Market Share by Application (2011-2016)
Figure United States Ophthalmic Drug Sales Market Share by Application in 2015
Table United States Ophthalmic Drug Sales Growth Rate by Application (2011-2016)
Figure United States Ophthalmic Drug Sales Growth Rate by Application (2011-2016)
Table Novartis Basic Information List
Table Novartis Ophthalmic Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis Ophthalmic Drug Sales Market Share (2011-2016)
Table Allergan Basic Information List
Table Allergan Ophthalmic Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Allergan Ophthalmic Drug Sales Market Share (2011-2016)
Table Santen Basic Information List
Table Santen Ophthalmic Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Santen Ophthalmic Drug Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Ophthalmic Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Ophthalmic Drug Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Ophthalmic Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Ophthalmic Drug Sales Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Ophthalmic Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Roche Ophthalmic Drug Sales Market Share (2011-2016)
Table Bayer Basic Information List
Table Bayer Ophthalmic Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Ophthalmic Drug Sales Market Share (2011-2016)
Table Senju Basic Information List
Table Senju Ophthalmic Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Senju Ophthalmic Drug Sales Market Share (2011-2016)
Table Regeneron Basic Information List
Table Regeneron Ophthalmic Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Regeneron Ophthalmic Drug Sales Market Share (2011-2016)
Table Valeant Basic Information List
Table Valeant Ophthalmic Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Valeant Ophthalmic Drug Sales Market Share (2011-2016)
Table Ozurdex Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Ophthalmic Drug
Figure Manufacturing Process Analysis of Ophthalmic Drug
Figure Ophthalmic Drug Industrial Chain Analysis
Table Raw Materials Sources of Ophthalmic Drug Major Manufacturers in 2015
Table Major Buyers of Ophthalmic Drug
Table Distributors/Traders List
Figure United States Ophthalmic Drug Production and Growth Rate Forecast (2016-2021)
Figure United States Ophthalmic Drug Revenue and Growth Rate Forecast (2016-2021)
Table United States Ophthalmic Drug Production Forecast by Type (2016-2021)
Table United States Ophthalmic Drug Consumption Forecast by Application (2016-2021)
Table United States Ophthalmic Drug Sales Forecast by States (2016-2021)
Table United States Ophthalmic Drug Sales Share Forecast by States (2016-2021)